Different responses to dexamethasone and prednisolone in the same depressed patients

Psychopharmacology

Volumn 189, Issue 2, 2006, Pages 225-235

  Juruena, Mario F ^a,b   Cleare, Anthony J ^a,b   Papadopoulos, Andrew S ^b   Poon, Lucia ^b   Lightman, Stafford ^c   Pariante, Carmine M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BETHLEM ROYAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Antidepressants; Childhood trauma; Cortisol; Depression; Glucocorticoid receptor; Hypothalamic pituitary adrenal (HPA) axis; Mineralocorticoid receptor

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; PLACEBO; PREDNISOLONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HOSPITAL PATIENT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INJURY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

AREA UNDER CURVE; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PREDNISOLONE; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; SALIVA; SALIVARY GLANDS; SINGLE-BLIND METHOD;

EID: 33750628603     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0555-4     Document Type: Article

References (70)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric, Washington, DC
2. Arana GW, Baldessarini RJ, Ornsteen M (1985) The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch Gen Psychiatry 42:1193-1204
3. Baldessarini RJ, Arana GW (1985) Does the dexamethasone suppression test have clinical utility in psychiatry? J Clin Psychiatry 46:25-29
4. Ballard PL, Carter JP, Graham BS, Baxter JD (1975) A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man. J Clin Endocrinol Metab 41:290-304
5. Bauer ME, Papadopoulos A, Poon L, Perks P, Lightman SL, Checkley S, Shanks N (2002) Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment-resistant depression. Psychiatry Res 113:1-15
6. Bauer ME, Papadopoulos A, Poon L, Perks P, Lightman SL, Checkley S, Shanks N (2003) Altered glucocorticoid immunoregulation in treatment resistant depression. Psychoneuroendocrinology 28:49-65
7. Beck At, Ward Ch, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
8. Bhagwagar Z, Hafizi S, Cowen PJ (2002) Acute citalopram administration produces correlated increases in plasma and salivary cortisol. Psychopharmacology (Berl) 163:118-120
9. Bhagwagar Z, Hafizi S, Cowen PJ (2003) Increase in concentration of waking salivary cortisol in recovered patients with depression. Am J Psychiatry 160:1890-1891
10. Bhagwagar Z, Hafizi S, Cowen PJ (2005) Increased salivary cortisol after waking in depression. Psychopharmacology (Berl) 182:54-57
11. Bjartmar L, Johansson IM, Marcusson J, Ross SB, Seckl JR, Olsson T (2000) Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat. Psychopharmacology (Berl) 151:7-12
12. Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Muller-Oerlinghausen B, Bauer M (2003) Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression. Depress Anxiety 17:43-48
13. Cooney JM, Dinan TG (1996a) Preservation of hypothalamic-pituitary- adrenal axis fast-feedback responses in depression. Acta Psychiatr Scand 94:449-453
14. Cooney JM, Dinan TG (1996b) Type II (glucocorticoid) receptors mediate fast-feedback inhibition of the hypothalamic-pituitary-adrenal axis in man. Life Sci 59:1981-1988
15. Cotter PA, Mulligan OF, Landau S, Papadopoulos A, Lightman SL, Checkley SA (2002) Vasoconstrictor response to topical beclomethasone in major depression. Psychoneuroendocrinology 27:475-487
16. Cowen PJ (2002) Cortisol, serotonin and depression: all stressed out? Br J Psychiatry 180:99-100
17. Crochemore C, Lu J, Wu Y, Liposits Z, Sousa N, Holsboer F, Almeida OF (2005) Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry 10:790-798
18. Czock D, Keller F, Rasche FM, Haussler U (2005) Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44:61-98
19. de Kloet ER, Vreugdenhil E, Oitzl MS, Joels M (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301
20. Gispen-de Wied CC, D'Haenen H, Verhoeven WM, Wynne HJ, Westenberg HG, Thijssen JH, van Ree JM (1993) Inhibition of the pituitary-adrenal axis with dexamethasone and cortisol in depressed patients and healthy subjects: a dose-response study. Psychoneuroendocrinology 18:191-204
21. Gispen-de Wied CC, Jansen LM, Wynne HJ, Matthys W, van der Gaag RJ, Thijssen JH, van Engeland H (1998) Differential effects of hydrocortisone and dexamethasone on cortisol suppression in a child psychiatric population. Psychoneuroendocrinology 23:295-306
22. Gispen-de Wied CC, Westenberg HG, Thijssen JH, van Ree JM (1987) The dexamethasone and cortisol suppression test in depression: beta-endorphin as a useful marker. Psychoneuroendocrinology 12:355-366
23. Guthrie S (1991) The impact of dexamethasone pharmacokinetics on the DST: a review. Psychopharmacol Bull 27:565-576
24. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
25. Harmer CJ, Bhagwagar Z, Shelley N, Cowen PJ (2003) Contrasting effects of citalopram and reboxetine on waking salivary cortisol. Psychopharmacology (Berl) 167:112-114
26. Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, Miller AH, Nemeroff CB (2000) Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284:592-597
27. Heuser IJ, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M, Yassouridis A, Holsboer F (1996) Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am J Psychiatry 153:93-99
28. Hill SA, Taylor MJ, Harmer CJ, Cowen PJ (2003) Acute reboxetine administration increases plasma and salivary cortisol. J Psychopharmacol 17:273-275
29. Inder WJ, Prickett TC, Mulder RT, Donald RA, Joyce PR (2001) Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine. Psychopharmacology (Berl) 156:73-78
30. Karssen AM, Meijer OC, van der Sandt I, de Boer AG, de Lange EC, de Kloet ER (2002) The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone. J Endocrinol 175:251-260
31. Kirschbaum C, Hellhammer DH (1994) Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 19:313-333
32. Kunzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S (2003) Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 28:2169-2178
33. Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Plotsky PM (2004) Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation. Biol Psychiatry 55:367-375
34. Lan NC, Matulich DT, Morris JA, Baxter JD (1981) Mineralocorticoid receptor-like aldosterone-binding protein in cell culture. Endocrinology 109:1963-1970
35. Lan NC, Graham B, Bartter FC, Baxter JD (1982) Binding of steroids to mineralocorticoid receptors: implications for in vivo occupancy by glucocorticoids. J Clin Endocrinol Metab 54:332-342
36. Liddle GW (1958) Studies of structure-function relationships of steroids. II. The 6-alpha-methylcorticosteroids. Metabolism 7:405-415
37. McAllister-Williams RH, Man MS, Young AH (1999) Effects of adrenalectomy on 8-OH-DPAT induced hypothermia in mice. Psychopharmacology (Berl) 142:73-77
38. McAllister-Williams RH, Anderson AJ, Young AH (2001) Corticosterone selectively attenuates 8-OH-DPAT-mediated hypothermia in mice. Int J Neuropsychopharmacol 4:1-8
39. Muller MB, Keck ME, Binder EB, Kresse AE, Hagemeyer TP, Landgraf R, Holsboer F, Uhr M (2003) ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder. Neuropsychopharmacology 28:1991-1999
40. Nikisch G, Mathe AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P (2005) Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology (Berl) 181:751-760
41. Orth D, Kovacs W (1998) The adrenal cortex. In: Wilson J, Foster D, Kronenberg H, Larsen P (eds) Williams textbook of endocrinology. W.B. Saunders Company, Philadelphia, pp 517-664
42. Pariante CM (2004) Glucocorticoid receptor function in vitro in patients with major depression. Stress 7:209-219
43. Pariante CM (2006) The glucocorticoid receptor: part of the solution or part of the problem? J Psychopharmacol 20:79-84
44. Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49:391-404
45. Pariante CM, Makoff A, Lovestone S, Feroli S, Heyden A, Miller AH, Kerwin RW (2001) Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br J Pharmacol 134:1335-1343
46. Pariante CM, Papadopoulos AS, Poon L, Checkley SA, English J, Kerwin RW, Lightman S (2002) A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis. Biol Psychiatry 51:922-930
47. Pariante CM, Hye A, Williamson R, Makoff A, Lovestone S, Kerwin RW (2003a) The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones. Neuropsychopharmacology 28:1553-1561
48. Pariante CM, Kim RB, Makoff A, Kerwin RW (2003b) Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters. Br J Pharmacol 139:1111-1118
49. Pariante CM, Papadopoulos AS, Poon L, Cleare AJ, Checkley SA, English J, Kerwin RW, Lightman S (2004a) Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers. Psychopharmacology (Berl) 177:200-206
50. Pariante CM, Thomas SA, Lovestone S, Makoff A, Kerwin RW (2004b) Do antidepressants regulate how cortisol affects the brain? 2003 Curt Richter Award Paper. Psychoneuroendocrinology 29:423-447
51. Portella MJ, Harmer CJ, Flint J, Cowen P, Goodwin GM (2005) Enhanced early morning salivary cortisol in neuroticism. Am J Psychiatry 162:807-809
52. Porter RJ, McAllister-Williams RH, Lunn BS, Young AH (1998) 5-Hydroxytryptamine receptor function in humans is reduced by acute administration of hydrocortisone. Psychopharmacology (Berl) 139:243-250
53. Porter RJ, McAllister-Williams RH, Jones S, Young AH (1999) Effects of dexamethasone on neuroendocrine and psychological responses to L-tryptophan infusion. Psychopharmacology (Berl) 143:64-71
54. Porter RJ, Gallagher P, Watson S, Young AH (2004) Corticosteroid- serotonin interactions in depression: a review of the human evidence. Psychopharmacology (Berl) 173:1-17
55. Post A, Ohl F, Almeida OF, Binder EB, Rucker M, Welt S, Binder E, Holsboer F, Sillaber I (2005) Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919). Psychopharmacology (Berl) 180:150-158
56. Reul JM, Gesing A, Droste S, Stec IS, Weber A, Bachmann C, Bilang-Bleuel A, Holsboer F, Linthorst AC (2000) The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur J Pharmacol 405:235-249
57. Reynolds RM, Bendall HE, Whorwood CB, Wood PJ, Walker BR, Phillips DI (1998) Reproducibility of the low dose dexamethasone suppression test: comparison between direct plasma and salivary cortisol assays. Clin Endocrinol (Oxf) 49:307-310
58. Ribeiro SC, Tandon R, Grunhaus L, Greden JF (1993) The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 150:1618-1629
59. Ritzi EM (1996) Quantitative flow cytometry reveals a hierarchy of glucocorticoid effect on cell surface mouse mammary tumor virus gp52. J Steroid Biochem Mol Biol 57:33-42
60. Rupprecht R, Reul JM, van Steensel B, Spengler D, Soder M, Berning B, Holsboer F, Damm K (1993) Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur J Pharmacol 247:145-154
61. Sackeim HA (2001) The definition and meaning of treatment-resistant depression. J Clin Psychiatry 62(Suppl 16):10-17
62. Slater JD, Heffron PF, Vernet A, Nabarro JD (1959) Clinical and metabolic effects of dexamethasone. Lancet 1:173-177
63. Smith N, Lam D, Bifulco A, Checkley S (2002) Childhood Experience of Care and Abuse Questionnaire (CECA.Q). Validation of a screening instrument for childhood adversity in clinical populations. Soc Psychiatry Psychiatr Epidemiol 37:572-579
64. Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS (2002) Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry 7:985-994
65. World Health Organisation (1994) Schedules for clinical assessment in neuropsychiatry (SCAN) Version 2.0., Geneva
66. Xing GQ, Russell S, Webster MJ, Post RM (2004) Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. Int J Neuropsychopharmacol 7:143-153
67. Yehuda R (2005) Neuroendocrine aspects of PTSD. Handb Exp Pharmacol 371-403
68. Young EA, Haskett RF, Murphy-Weinberg V, Watson SJ, Akil H (1991) Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry 48:693-699
69. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H (2003) Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 60:24-28
70. Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M (2001) Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J Psychiatr Res 35:83-94